Intellectual property


Medical Industry Leadership Institute

Event will Spotlight the Intersection of Artificial Intelligence and Health Care

August 16, 2018

On Oct. 3, the the Medical Industry Leadership Institute at the Carlson School of Management will host the Convene conference, which aims to bring together university researchers and the health care industry. This year's focus is artificial intelligence; the keynote speaker is Dr. Peter Pronovost, Chief Medical Officer of United Healthcare, who will discuss the "Journey to High Value Healthcare." Also featured is John Hammergren, CEO of McKesson Corporation; he'll be joined by Prof. Stephen Parente to discuss health case and data analytics. University of Minnesota faculty, staff, students and alumni are eligible for discounted tickets -- learn more and register here


Pipette and beaker with liquid being transferred

University Honored for Generating New Companies

May 16, 2018

In the 12 years since the University of Minnesota established its Office for Technology Commercialization (OTC) in 2006, more than 120 new companies have been founded based on the U's diverse research activities. Now, OTC is a finalist for an international award recognizing the best academic technology transfer units in the world. According to Twin Cities Business, the other nominees are comparable units at Indiana University, Johns Hopkins, Oxford and Yissum (Hebrew University of Jerusalem). Vice President for Research Allen Levine said "We are thrilled to see the University of Minnesota receive global recognition. . . . It is a testament to our efforts. . . to foster entrepreneurship, connect with the private sector and accelerate the transfer of knowledge to benefit the public good.”  The winner will be announced on May 22 in London. Several faculty members affiliated with the Consortium have launched companies in partnership with OTC, including Kenny Beckman (University of Minnesota Genomics Center, Corebiome); Bruce Blazer (Clinical and Translational Science Institute, Tmunity Therapeutics); and Michael Sadowsky and Alexander Khoruts (BioTechnology Institute, CIPAC – Crestovo LLC).


Man in lab with microscopes and test tubes

New Models for Funding Science Research Proposed

October 14, 2016

An article in The Conversation poses an urgent question: In light of declining federal support, is it time for a new funding model for scientific research in higher education? The answer, according to University of Minnesota Vice President for Research Brian Herman and Claudia Neuhauser, Associate Vice President for Research, is a resounding yes: "The hard fact is that there’s just not enough R&D money available to support the higher ed research capabilities our country has built." The dilemma, however, is that despite efforts to diversify funding sources to include business, philanthropy and other nonprofits, those types of partners rarely subsidize the basic research that "provides the necessary foundation for many of the products and services that contribute to the nation’s wealth." Herman and Neuhauser explore several solutions, including closer collaboration between research universities and radically redefining the "shared value" of research and development to both academic and private enterprise. Read the entire article here